Using mind control to modify cue-reactivity in AUD: the impact of mindfulness-based relapse prevention on real-time fMRI neurofeedback to modify cue-reactivity in alcohol use disorder : a randomized controlled trial
Alcohol Use Disorder is a severe mental disorder affecting the individuals concerned, their family and friends and society as a whole. Despite its high prevalence, novel treatment options remain rather limited. Two innovative interventions used for treating severe disorders are the use of real-time...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
16 June 2020
|
| In: |
BMC psychiatry
Year: 2020, Volume: 20 |
| ISSN: | 1471-244X |
| DOI: | 10.1186/s12888-020-02717-7 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12888-020-02717-7 |
| Author Notes: | Franziska Weiss, Acelya Aslan, Jingying Zhang, Martin Fungisai Gerchen, Falk Kiefer and Peter Kirsch |
| Summary: | Alcohol Use Disorder is a severe mental disorder affecting the individuals concerned, their family and friends and society as a whole. Despite its high prevalence, novel treatment options remain rather limited. Two innovative interventions used for treating severe disorders are the use of real-time functional magnetic resonance imaging neurofeedback that targets brain regions related to the disorder, and mindfulness-based treatments. In the context of the TRR SFB 265 C04 “Mindfulness-based relapse prevention as an addition to rtfMRI NFB intervention for patients with Alcohol Use Disorder (MiND)” study, both interventions will be combined to a state-of-the art intervention that will use mindfulness-based relapse prevention to improve the efficacy of a real-time neurofeedback intervention targeting the ventral striatum, which is a brain region centrally involved in cue-reactivity to alcohol-related stimuli. |
|---|---|
| Item Description: | Gesehen am 12.08.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1471-244X |
| DOI: | 10.1186/s12888-020-02717-7 |